In this paraneoplastic syndrome, the increased production of FGF23, in line with its main endocrine effects, induces renal phosphate excretion and reduction of 1,25(OH)2D3, causing osteomalacia and demineralised bone [19]. The gene discussed is FGF23; the disease is osteomalacia.